Stratec Se

Stratec Se Assets per Share

The Total Assets per Share of Stratec Se (SBS.DE) as of Oct 9, 2026 is 36.47 EUR. In the previous year, Total Assets per Share was 36.61 EUR — a change of -0.38% (lower).

Assets per Share

36.47EUR

YoY

-0.38%

Last updated:

Total Assets per Share of Stratec Se is 2025 36.47 EUR. Total Assets per Share of Stratec Se was 2024 36.61 EUR. It decreases by -0.38% lower compared to the previous year.

The Stratec Se Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
22.65 EUR
Jan 1, 2019
24.63 EUR
Jan 1, 2020
27.30 EUR
Jan 1, 2021
30.32 EUR
Jan 1, 2022
32.70 EUR
Jan 1, 2023
38.38 EUR
Jan 1, 2024
36.61 EUR
Jan 1, 2025
36.47 EUR
The Stratec Se Assets per Share history
YEARAssets per ShareYoY
36.47EUR-0.38%
36.61EUR-4.61%
38.38EUR+17.38%
32.70EUR+7.86%
30.32EUR+11.03%
27.30EUR+10.85%
24.63EUR+8.77%
22.65EUR+4.36%
21.70EUR+2.25%
21.22EUR+62.31%
13.08EUR+15.38%
11.33EUR—
Access this data via the Eulerpool API

Stratec Se Stock analysis

What does Stratec Se do? The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stratec Se stock

Total Assets per Share of Stratec Se is 36.47 EUR in 2025.

Total Assets per Share of Stratec Se changed from 36.61 EUR to 36.47 EUR, representing a -0.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Stratec Se since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

Other — Stratec Se

All Key Metrics — Stratec Se